Our News on Newswise

Newswise: sonisj-1.jpg

Approval processes for clinical practice guidelines introduce potential conflicts of interest, review finds

A new study of the approval processes used by the 43 medical-specialty-society members of the Council of Medical Specialty Societies in the U.S. to create evidence-based guidelines finds that most use an approval procedure that has the potential to...
13-Feb-2020 9:00 AM EST Add to Favorites

Newswise: MT1_1.png

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to MT1 Receptors

If translatable into humans, this research published in Nature could help scientists create targeted therapies to mimic or counteract the actions of melatonin, which is implicated in numerous circadian disorders, in problems associated with working...
12-Feb-2020 10:00 AM EST Add to Favorites

Newswise: Smith_Jennifer.jpg

Study shows promise for urine-based test for HPV-linked cervical cancer

In a recent study published in the Journal of Clinical Microbiology, researchers compared urine testing to other screening methods in detecting women at risk for HPV-linked cervical cancer. While they found the urine test showed promise, additional...
7-Feb-2020 10:15 AM EST Add to Favorites

Newswise: GU_PATCH_lowres.jpg

Researchers successfully test coin-sized smart insulin patch, potential diabetes treatment

UCLA bioengineers and colleagues at UNC School of Medicine and MIT have further developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people with diabetes and deliver the necessary insulin dosage.
4-Feb-2020 4:55 PM EST Add to Favorites

Newswise: PreferredHORIZ_9B7A5817.jpg

Discovery would allow researchers to fine-tune CAR-T activity

In a study published in Cancer Cell, researchers reported new findings about the regulation of co-stimulatory molecules that could be used to activate cancer-killing immune cells – chimeric antigen receptor T-cells, or CAR-T – or decrease their...
28-Jan-2020 9:05 AM EST Add to Favorites

Researchers Reverse HIV Latency, Important Scientific Step Toward Cure

Overcoming HIV latency – activating HIV in CD4+ T cells that lay dormant – is a needed step toward a cure. Scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics – a partnership between UNC and ViiV Healthcare – showed it’s...
21-Jan-2020 11:10 AM EST Add to Favorites

Newswise: george-stouffer.jpg

Improving Cardiovascular Health of the Most Vulnerable

Starting in 2016, a two-year partnership between the North Carolina Chapter of the American College of Cardiology (NCACC) and the North Carolina Association of Free and Charitable Clinics (NCAFCC) provided free lipid lowering therapy and clopidogrel...
21-Jan-2020 3:35 PM EST Add to Favorites

Researchers Detail Academic Scholarships Offered by E-Cigarette Entities

UNC School of Medicine researchers conducted a systematic online review and found 21 vaping-related companies, including, websites, that promoted 40 scholarships to high school and college students in 2018 across the United States.
8-Jan-2020 5:05 PM EST Add to Favorites


See All News

Our Experts on Newswise

UNC Lineberger Experts Available at AACR Annual Meeting 2018

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center experts are available to provide expert commentary and feedback on research presented at the AACR Annual Meeting 2018.
13-Apr-2018 10:05 AM EDT

Newswise: Egan.jpeg

UNC Expert Publishes Commentary About Recent Change in Donor Lung Allocation Policy

Dr. Thomas Egan of the University of North Carolina School of Medicine says that a recent change in donor lung allocation policy was long overdue. However, because the change happened over the Thanksgiving holiday weekend in response to litigation,...
16-Jan-2018 10:05 AM EST

UNC Health Care, UNC School of Medicine Launch Zika Research Experts’ Page

UNC Health Care and the UNC School of Medicine have launched a tool for media to request interviews with experts and researchers at the forefront of the global Zika research initiative.
12-Jul-2016 9:05 AM EDT

Newswise: Piven.jpg

#UNC Experts Available for Interviews for #Autism Awareness Month

20-Mar-2014 3:00 PM EDT

Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer

In the editorial, the UNC researchers explain the excitement about this new class of drugs and the importance of this trial. They also highlight the reasons that caution as well as enthusiasm is warranted.
3-Jan-2011 2:50 PM EST

Newswise: DeWalt.jpg

UNC Expert Available to Discuss JAMA Study on Over-the-Counter Dosing of Children

Dr. Darren DeWalt, author of a JAMA editorial being released early online this week, is available for media interviews.
29-Nov-2010 11:45 AM EST

Expert Available to Discuss Latest AIDS Vaccine Trial

UNC expert available to discuss latest development in search for AIDS vaccine.
24-Sep-2009 12:40 PM EDT

It Takes Two (Or More)

UNC brain surgeon Anand Germanwala, M.D. and ENT surgeon Adam Zanation, M.D., collaborated to develop through-the-nose approach to repair a patient's ruptured brain aneurysm.
26-Aug-2009 9:00 AM EDT

See All Experts

Our YouTube Videos

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Contacts

Phil Bridges
Director of Communications

phil.bridges@unchealth.unc.edu

984-974-1152

Mark Derewicz
Communications Manager
Basic Science

mark.derewicz@unchealth.unc.edu

Tom Hughes
Media Relations/Social Media Strategist
Clinical medicine

Tom.Hughes@unchealth.unc.edu

984-974-1151

Courtney Mitchell

Courtney.Mitchell@unchealth.unc.edu

919-843-4927

Laura Oleniacz
science communications manager
cancer research medicine

loleniac@email.unc.edu

919-812-0621

Jamie Williams
Information and Communications Specialist

Jamie.Williams@unchealth.unc.edu

984-974-1149

Twitter

close
Chat now!
0.66492